Therapeutic Drug Monitoring of Imatinib, Nilotinib, and Dasatinib for Patients With Chronic Myeloid Leukemia
Biological and Pharmaceutical Bulletin - Japan
doi 10.1248/bpb.b15-00103
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2015
Authors
Publisher
Pharmaceutical Society of Japan